A U.K. study suggests an annual coronavirus booster shot may be necessary

Early this year, reports of people in South Korea testing positive for the coronavirus again after apparently recovering set off alarm bells. The concern largely subsided, however, when the Korean Centers for Disease Control and Prevention determined the positive tests weren't reinfections.
Now, though, a new study from King's College in London suggests people may lose their COVID-19 immunity within months. The study analyzed the immune response of more than 90 patients and health-care workers, with blood tests revealing 60 percent developed a strong antibody response during their infections, but only 17 percent retained the same potency three months later. In some cases, antibody levels weren't detectable.
Along those lines, Vox reported a case in which a patient tested positive for the virus three months after their initial infection. While the doctor in the case noted it's possible a single infection lasted that long, he's doubtful. Plus, other coronaviruses that cause common colds don't lead to long-term immunity, so some experts think the novel virus is headed down that path.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The results of the study indicate it could be challenging to develop herd immunity or a one-and-done vaccine, but there are several important pieces of information to process. The King's College participants haven't been reinfected, so it's not a sure thing it can even happen. Similarly, the Vox anecdote is a may not be representative, and there haven't been similar reports out of countries hit by the virus earlier than the U.S.
Secondly, Prof. Robin Shattock of Imperial College London said even if reinfection is possible, subsequent cases would likely "be less severe" because people "will still retain immune memory."
Lastly, this wouldn't mean there's no hope for a vaccine, but rather, like the flu, an annual coronavirus booster shot may be necessary for "sustained levels of protective antibodies." Read more at The Guardian.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Amazon's 'James Bond' deal could mean a new future for 007
In the Spotlight The franchise was previously owned by the Broccoli family
By Justin Klawans, The Week US Published
-
Why are Republicans suddenly panicking about DOGE?
TODAY'S BIG QUESTION As Trump and Musk take a chainsaw to the federal government, a growing number of Republicans worry that the massive cuts are hitting a little too close to home
By Rafi Schwartz, The Week US Published
-
What is JD Vance's Net Worth?
In Depth The vice president is rich, but not nearly as wealthy as his boss and many of his boss' appointees
By David Faris Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published